Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 2
2017 2
2018 2
2019 1
2020 1
2021 5
2022 6
2023 7
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Interactive enhancer hubs (iHUBs) mediate transcriptional reprogramming and adaptive resistance in pancreatic cancer.
Hamdan FH, Abdelrahman AM, Kutschat AP, Wang X, Ekstrom TL, Jalan-Sakrikar N, Wegner Wippel C, Taheri N, Tamon L, Kopp W, Aggrey-Fynn J, Bhagwate AV, Alva-Ruiz R, Lynch I, Yonkus J, Kosinsky RL, Gaedcke J, Hahn SA, Siveke JT, Graham R, Najafova Z, Hessmann E, Truty MJ, Johnsen SA. Hamdan FH, et al. Among authors: abdelrahman am. Gut. 2023 Jun;72(6):1174-1185. doi: 10.1136/gutjnl-2022-328154. Epub 2023 Mar 8. Gut. 2023. PMID: 36889906 Free PMC article.
Identification of a ΔNp63-Dependent Basal-Like A Subtype-Specific Transcribed Enhancer Program (B-STEP) in Aggressive Pancreatic Ductal Adenocarcinoma.
Wang X, Kutschat AP, Aggrey-Fynn J, Hamdan FH, Graham RP, Wixom AQ, Souto Y, Ladigan-Badura S, Yonkus JA, Abdelrahman AM, Alva-Ruiz R, Gaedcke J, Ströbel P, Kosinsky RL, Wegwitz F, Hermann P, Truty MJ, Siveke JT, Hahn SA, Hessmann E, Johnsen SA, Najafova Z. Wang X, et al. Among authors: abdelrahman am. Mol Cancer Res. 2023 Sep 1;21(9):881-891. doi: 10.1158/1541-7786.MCR-22-0916. Mol Cancer Res. 2023. PMID: 37279184 Free PMC article.
Neoadjuvant Chemotherapy Switch in Borderline Resectable/Locally Advanced Pancreatic Cancer.
Alva-Ruiz R, Yohanathan L, Yonkus JA, Abdelrahman AM, Gregory LA, Halfdanarson TR, Mahipal A, McWilliams RR, Ma WW, Hallemeier CL, Graham RP, Grotz TE, Smoot RL, Cleary SP, Nagorney DM, Kendrick ML, Truty MJ. Alva-Ruiz R, et al. Among authors: abdelrahman am. Ann Surg Oncol. 2022 Mar;29(3):1579-1591. doi: 10.1245/s10434-021-10991-2. Epub 2021 Nov 1. Ann Surg Oncol. 2022. PMID: 34724125 Free PMC article.
Microsurgical skills training course and impact on trainee confidence and workload.
Mohan AT, Abdelrahman AM, Anding WJ, Lowndes BR, Blocker RC, Hallbeck MS, Bakri K, Moran SL, Mardini S. Mohan AT, et al. Among authors: abdelrahman am. J Plast Reconstr Aesthet Surg. 2022 Jul;75(7):2135-2142. doi: 10.1016/j.bjps.2022.02.004. Epub 2022 Feb 19. J Plast Reconstr Aesthet Surg. 2022. PMID: 35346609
Synergistic combination of cytotoxic chemotherapy and cyclin-dependent kinase 4/6 inhibitors in biliary tract cancers.
Arora M, Bogenberger JM, Abdelrahman AM, Yonkus J, Alva-Ruiz R, Leiting JL, Chen X, Serrano Uson Junior PL, Dumbauld CR, Baker AT, Gamb SI, Egan JB, Zhou Y, Nagalo BM, Meurice N, Eskelinen EL, Salomao MA, Kosiorek HE, Braggio E, Barrett MT, Buetow KH, Sonbol MB, Mansfield AS, Roberts LR, Bekaii-Saab TS, Ahn DH, Truty MJ, Borad MJ. Arora M, et al. Among authors: abdelrahman am. Hepatology. 2022 Jan;75(1):43-58. doi: 10.1002/hep.32102. Epub 2021 Dec 12. Hepatology. 2022. PMID: 34407567
"Answers in hours": A prospective clinical study using nanopore sequencing for bile duct cultures.
Yonkus JA, Whittle E, Alva-Ruiz R, Abdelrahman AM, Horsman SE, Suh GA, Cunningham SA, Nelson H, Grotz TE, Smoot RL, Cleary SP, Nagorney DM, Kendrick ML, Patel R, Truty MJ, Chia N. Yonkus JA, et al. Among authors: abdelrahman am. Surgery. 2022 Mar;171(3):693-702. doi: 10.1016/j.surg.2021.09.037. Epub 2021 Dec 29. Surgery. 2022. PMID: 34973809 Free article.
Patency rates of hepatic arterial resection and revascularization in locally advanced pancreatic cancer.
Alva-Ruiz R, Abdelrahman AM, Starlinger PP, Yonkus JA, Moravec DN, Busch JJ, Fleming CJ, Andrews JC, Mendes BC, Colglazier JJ, Smoot RL, Cleary SP, Nagorney DM, Kendrick ML, Truty MJ. Alva-Ruiz R, et al. Among authors: abdelrahman am. HPB (Oxford). 2022 Nov;24(11):1957-1966. doi: 10.1016/j.hpb.2022.06.005. Epub 2022 Jun 16. HPB (Oxford). 2022. PMID: 35780039 Free article.
FDG-PET Predicts Neoadjuvant Therapy Response and Survival in Borderline Resectable/Locally Advanced Pancreatic Adenocarcinoma.
Abdelrahman AM, Goenka AH, Alva-Ruiz R, Yonkus JA, Leiting JL, Graham RP, Merrell KW, Thiels CA, Hallemeier CL, Warner SG, Haddock MG, Grotz TE, Tran NH, Smoot RL, Ma WW, Cleary SP, McWilliams RR, Nagorney DM, Halfdanarson TR, Kendrick ML, Truty MJ. Abdelrahman AM, et al. J Natl Compr Canc Netw. 2022 Sep;20(9):1023-1032.e3. doi: 10.6004/jnccn.2022.7041. J Natl Compr Canc Netw. 2022. PMID: 36075389
Biliary tract cancer patient-derived xenografts: Surgeon impact on individualized medicine.
Leiting JL, Murphy SJ, Bergquist JR, Hernandez MC, Ivanics T, Abdelrahman AM, Yang L, Lynch I, Smadbeck JB, Cleary SP, Nagorney DM, Torbenson MS, Graham RP, Roberts LR, Gores GJ, Smoot RL, Truty MJ. Leiting JL, et al. Among authors: abdelrahman am. JHEP Rep. 2020 Jan 16;2(2):100068. doi: 10.1016/j.jhepr.2020.100068. eCollection 2020 Apr. JHEP Rep. 2020. PMID: 32181445 Free PMC article.
In vivo label-free optical signatures of chemotherapy response in human pancreatic ductal adenocarcinoma patient-derived xenografts.
Park J, Sorrells JE, Chaney EJ, Abdelrahman AM, Yonkus JA, Leiting JL, Nelson H, Harrington JJ, Aksamitiene E, Marjanovic M, Groves PD, Bushell C, Truty MJ, Boppart SA. Park J, et al. Among authors: abdelrahman am. Commun Biol. 2023 Sep 25;6(1):980. doi: 10.1038/s42003-023-05368-y. Commun Biol. 2023. PMID: 37749184 Free PMC article.
22 results